Skip to content

Ceribell

US · CBLL #3313 by market cap Listed 2024
23.63 +0.48 +2.07%
Live - 5344 symbols - heartbeat 97s ago · 2026-10-09 19:30

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 1 in the most recent period (2026/Q3).
  • Total institutional ownership fell 0.3 percentage points.

Institutional ownership

Held by institutions
95.62% -0.32pp
Institutions
167 +1
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Diverging

Institutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund48.00%
VC/PE Fund23.61%
Hedge Fund9.50%
Private Company7.62%
Individual/Insider5.50%
Family Office/Trust4.10%
Public Company2.59%
Insurance Company0.14%

Top holders as of 2026-06-30

FMR 14.83% · 5.69M sh
TPG Capital, L.P. 9.80% · 3.76M sh
Longitude Capital Management Co., LLC 6.45% · 2.48M sh
Red Tree Venture Capital 5.75% · 2.21M sh
BlackRock 5.04% · 1.94M sh
The Global Value Investment Portfolio Management Pte Ltd. 4.10% · 1.57M sh
Vanguard Capital Management, LLC 3.38% · 1.30M sh
ACP Trust 3.33% · 1.28M sh
Kcm Capital, Inc. 2.93% · 1.13M sh
Xingjuan Chao 2.51% · 961.45K sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 10 buys · 40 sells

NameRoleStake
Xingjuan Chao Chief Executive Officer 2.51%
Josef Parvizi Director, Co-Founder & Chief Medical Advisor 1.86%
Raymond Woo Chief Technology Officer 0.40%
Scott Blumberg Chief Financial Officer 0.25%
Joseph Manni Officer 0.15%
Joseph Taylor Independent Director 0.13%
David Foehr Officer 0.09%
Rebecca Robertson Independent Chairperson 0.07%
William Burke Independent Director 0.04%
Juliet Bakker Independent Director 0.02%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-30 Raymond Woo Chief Technology Officer Derivative Exercise and Sale -4,887 $3.65–24.38
2026-09-14 Scott Blumberg Chief Financial Officer Derivative Exercise and Sale -846 $9.41–25.00
2026-09-14 Xingjuan Chao Chief Executive Officer Automatic Disposition -20,846 $25.03
2026-09-07 Raymond Woo Chief Technology Officer Derivative Exercise and Sale -4,887 $3.65–24.33
2026-09-07 Raymond Woo Chief Technology Officer Derivative Exercise and Retained +8,389 $2.24
2026-09-07 David Foehr Officer Automatic Disposition -1,755 $24.26
2026-09-07 David Foehr Officer Derivative Exercise and Sale -7,500 $4.70–24.25
2026-09-01 Scott Blumberg Chief Financial Officer Derivative Exercise and Sale -652 $9.41–25.00
2026-09-01 Xingjuan Chao Chief Executive Officer Automatic Disposition -14,540 $24.61
2026-09-01 Xingjuan Chao Chief Executive Officer Derivative Exercise and Sale -25,000 $4.70–24.61
2026-08-23 David Foehr Officer Automatic Disposition -859 $23.95
2026-08-20 Scott Blumberg Chief Financial Officer Open Market Disposition -1,521 $24.02
2026-08-20 Xingjuan Chao Chief Executive Officer Open Market Disposition -6,068 $24.02
2026-08-20 Raymond Woo Chief Technology Officer Open Market Disposition -1,979 $24.02
2026-08-20 Joseph Manni Officer Open Market Disposition -1,361 $24.02
2026-08-20 David Foehr Officer Open Market Disposition -993 $24.02
2026-08-18 Scott Blumberg Chief Financial Officer Derivative Exercise and Sale -34,502 $4.70–25.03
2026-08-18 Scott Blumberg Chief Financial Officer Intent to Sell (Form 144) -33,512 $25.03
2026-08-18 Xingjuan Chao Chief Executive Officer Automatic Disposition -33,614 $25.00–25.03
2026-08-18 Xingjuan Chao Chief Executive Officer Intent to Sell (Form 144) -31,415 $25.03

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-09 19:30:04 · For reference only, not investment advice and not tailored to your situation.

Ceribell discussion 0 comments

Add a comment